Department of Experimental Psychology University of Oxford, Oxford, UK.
Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Neuropsychopharmacology. 2018 Apr;43(5):1107-1118. doi: 10.1038/npp.2017.231. Epub 2017 Sep 26.
Sickness behavior in humans is characterized by low mood and fatigue, which have been suggested to reflect changes in motivation involving reorganization of priorities. However, it is unclear which specific processes underlying motivation are altered. We tested whether bacterial endotoxin E. coli lipopolysaccharide (LPS) affected two dissociable constructs of motivational behavior, ie, effort and reward sensitivity. After familiarization with 5 effort levels, participants made a series of accept/reject decisions on whether the stake offered (1, 4, 8, 12, or 15 apples) was 'worth the effort' (10%, 27.5%, 45%, 62.5%, and 80% of maximal voluntary contraction in a hand-held dynamometer). Effort and reward levels were parametrically modulated to dissociate their influence on choice. Overall, 29 healthy young males were administered LPS (2 ng/kg; n=14) or placebo (0.9% saline; n=15). The effort-stake task, and self-reported depression and fatigue were assessed prior to LPS/placebo injection, 2 and 5 h post injection. Cytokines and sickness symptoms were assessed hourly till 8 h after LPS injection. LPS transiently increased interleukin-6 and tumor necrosis factor-α, sickness symptoms, body temperature and self-reported fatigue, and depression post injection relative to baseline and placebo. These changes were accompanied by LPS-induced decreases in acceptance rates of high-effort options, without significantly affecting reward sensitivity 2 h post injection, which were partially recovered 5 h post injection. We suggest that LPS-induced changes in motivation may be due to alterations to mesolimbic dopamine. Our behavioral paradigm could be used to further investigate effects of inflammation on motivational behavior in psychiatric and chronic illnesses.
人类的患病行为表现为情绪低落和疲劳,这被认为反映了动机的变化,涉及到优先级的重新组织。然而,目前尚不清楚哪些特定的动机过程发生了改变。我们测试了细菌内毒素大肠杆菌脂多糖(LPS)是否会影响动机的两个可分离结构,即努力和奖励敏感性。在熟悉了 5 个努力水平后,参与者就提供的赌注(1、4、8、12 或 15 个苹果)是否“值得努力”(手测力计上最大自主收缩的 10%、27.5%、45%、62.5%和 80%)做出了一系列接受/拒绝决策。努力和奖励水平被参数化调节,以分离它们对选择的影响。总体而言,29 名健康年轻男性接受了 LPS(2ng/kg;n=14)或安慰剂(0.9%生理盐水;n=15)治疗。在 LPS/安慰剂注射前、注射后 2 和 5 小时评估了努力-赌注任务以及自我报告的抑郁和疲劳情况。在 LPS 注射后直到 8 小时,每小时评估细胞因子和患病症状。与基线和安慰剂相比,LPS 注射后会短暂增加白细胞介素-6 和肿瘤坏死因子-α、患病症状、体温和自我报告的疲劳和抑郁。这些变化伴随着 LPS 诱导的高努力选择接受率下降,但在注射后 2 小时,对奖励敏感性没有显著影响,在注射后 5 小时部分恢复。我们认为,LPS 诱导的动机变化可能是由于中脑边缘多巴胺的改变。我们的行为范式可以用于进一步研究炎症对精神病和慢性疾病中动机行为的影响。